Cardiac Glycosides And Anticancer Activity
Yuan Hsu Lin, Dapeng Chen, Li Wang, Dong-mei Ye
Published 2013 · Chemistry
Download PDFAnalyze on Scholarcy
This paper references
Cardiotonic steroids on the road to anti-cancer therapy.
T. Mijatovic (2007)
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis
A. Perne (2009)
Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines.
F. Verheye-Dua (1998)
p53 as a target for anti-cancer drug development.
B. Bouchet (2006)
Cardiac glycosides inhibit TNF-α/NF-κB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor
Qingfeng Yang (2005)
Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function.
Z. Xie (2003)
Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
J. M. Fortune (2000)
Digitoxin medication and cancer; case control and internal dose-response studies
J. Haux (2001)
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
R. Sen (1986)
DNA Topoisomerase II as a Target for Cancer Chemotherapy
J. Walker (2002)
Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
S. Frese (2006)
Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
S. Manna (2000)
CARDIAC GLYCOSIDES AND BREAST CANCER
B. Stenkvist (1979)
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.
Craig D. Simpson (2009)
RETRACTED ARTICLE: Oleandrin-Mediated Expression of Fas Potentiates Apoptosis in Tumor Cells
Yashin Sreenivasan (2006)
Cardiac glycosides as novel cancer therapeutic agents.
R. Newman (2008)
Oleandrin induces apoptosis in human, but not in murine cells: dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity.
Pongali B. Raghavendra (2007)
Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels
N. Arispe (2008)
Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase.
M. Haas (2000)
Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.
C. Antczak (2009)
Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate.
W. O'Brien (1994)
Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications.
R. Biggar (2012)
Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition.
Z. Wang (2009)
Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell.
H. Wang (2011)
High-Throughput Screening Identifies Cardiac Glycosides as Potent Inhibitors of Human Tissue Kallikrein Expression: Implications for Cancer Therapies
I. Prassas (2008)
Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study
T. Ahern (2008)
Letter: Von Wollebrand's disease.
Graham Jb (1974)
Is digitalis a therapy for breast carcinoma?
B. Stenkvist (1999)
Oleandrin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 and potentiates apoptosis induced by ceramide.
Yashin Sreenivasan (2003)
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
W. Kaelin (2005)
Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.
K. Bielawski (2006)
Digitoxin and its analogs as novel cancer therapeutics
Hosam A. Elbaz (2012)
Up‐regulation of Na+,K+‐ATPase α3‐isoform and down‐regulation of the α1‐isoform in human colorectal cancer
H. Sakai (2004)
Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets
P. Yang (2009)